All In Biotech

Free tool

FAERS Monitor: Gazyva

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125486 or its brand name (Gazyva, Obinutuzumab). Reports on generic versions are filed under their own applications.

Reports

16,929

Serious

14,235

84% of reports

Hospitalization

6,290

Death reported

2,206

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,999
  • neutropenia1,407
  • covid-191,094
  • febrile neutropenia1,049
  • pyrexia1,027
  • thrombocytopenia963
  • disease progression961
  • infusion related reaction882
  • pneumonia805
  • anaemia737
  • infection625
  • atrial fibrillation606
  • death557
  • cytokine release syndrome547
  • myelosuppression547

Reports by year received

View as table
YearReports
20112
201219
2013122
2014410
2015375
2016689
2017850
20181,074
2019950
20201,195
20211,177
20222,314
20232,103
20242,473
20251,689
20261,487

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,230 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cytokine release syndromeSignal54734.832.017,453
febrile neutropeniaSignal1,04919.918.818,621
myelosuppressionSignal54719.117.69,262
infusion related reactionSignal88216.715.712,906
neutropeniaSignal1,40713.012.315,485
thrombocytopeniaSignal96310.810.18,510
disease progressionSignal96110.29.67,912
covid-19Signal1,0947.87.46,481
atrial fibrillationSignal6067.87.23,564
infectionSignal6255.45.02,232
anaemiaSignal7374.84.52,236
pyrexiaSignal1,0273.73.52,044
pneumoniaSignal8053.12.91,154
off label useSignal1,9992.82.72,480
death5570.80.728

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.